N/A
N=68
iCare vs Tonopen vs Goldmann Applanation Post-vitrectomy Surgery
Intraocular Pressure
Bottom Line
View on ClinicalTrials.gov: NCT01786954 ↗Enrolled (actual)
68
Serious AEs
0.0%
Results posted
Feb 2016
Primary outcome: Primary: Measurement of Intraocular Pressure — 15.9; 16.0; 16.9 mm Hg
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Icare rebound tonometry (Device); Tonopen applanation (Device); Goldmann applanation (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Duke University
- Primary completion
- Sep 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Measurement of Intraocular Pressure |
15.9; 16.0; 16.9 | — |
| SECONDARY Adverse Events |
0; 0; 0 | — |
Summary
The purpose of the study is to compare the measurement of pressure inside the eye using three different FDA-approved devices (Icare, Tonopen, and Goldmann applanation).
Eligibility Criteria
Inclusion Criteria
- Duke Eye Center patients 18 years or older
- capacity to give legally effective consent
- scheduled to undergo vitreoretinal surgery
Exclusion Criteria
- individuals unable to give consent
- minors
Data sourced from ClinicalTrials.gov (NCT01786954). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.